A thymus-specific noncoding RNA, Thy-ncR1, is a cytoplasmic riboregulator of MFAP4 mRNA in immature T-cell lines by Aoki, Kazuma et al.
RESEARCH ARTICLE Open Access
A thymus-specific noncoding RNA, Thy-ncR1, is a
cytoplasmic riboregulator of MFAP4 mRNA in
immature T-cell lines
Kazuma Aoki
1,2, Akira Harashima
3, Miho Sano
1,2, Takahide Yokoi
4, Shuji Nakamura
3, Masayoshi Kibata
3,
Tetsuro Hirose
1*
Abstract
Background: Postgenomic transcriptome analyses have identified large numbers of noncoding (nc)RNAs in
mammalian cells. However, the biological function of long ncRNAs in mammalian cells remains largely unknown.
Our recent expression profiling of selected human long ncRNAs revealed that a majority were expressed in an
organ-specific manner, suggesting their function was linked to specific physiological phenomena in each organ.
We investigated the characteristics and function of ncRNAs that were specifically expressed in the thymus, the site
of T-cell selection and maturation.
Results: Expression profiling of 10 thymus-specific ncRNAs in 17 T-cell leukemia cell lines derived from various
stages of T-cell maturation revealed that HIT14168 ncRNA, named Thy-ncR1, was specifically expressed in cell lines
derived from stage III immature T cells in which the neighbouring CD1 gene cluster is also specifically activated.
The Thy-ncR1 precursor exhibited complex alternative splicing patterns and differential usage of the 5’ terminus
leading to the production of an estimated 24 isoforms, which were predominantly located in the cytoplasm.
Selective RNAi knockdown of each Thy-ncR1 isoform demonstrated that microfibril-associated glycoprotein 4
(MFAP4) mRNA was negatively regulated by two major Thy-ncR1 isoforms. Intriguingly, the MFAP4 mRNA level was
controlled by a hUPF1-dependent mRNA degradation pathway in the cytoplasm distinct from nonsense-mediated
decay.
Conclusions: This study identified Thy-ncR1 ncRNA to be specifically expressed in stage III immature T cells in
which the neighbouring CD1 gene cluster was activated. Complex alternative splicing produces multiple Thy-ncR1
isoforms. Two major Thy-ncR1 isoforms are cytoplasmic riboregulators that suppress the expression of MFAP4
mRNA, which is degraded by an uncharacterized hUPF1-dependent pathway.
Background
Recent postgenomic transcriptome analyses, including
cDNA sequencing and tiling array analyses, have
revealed that large numbers of transcripts unlikely to
encode polypeptides are produced from regions covering
a large fraction of the human and mouse genomes [1-6].
A recent report from the ENCODE project [4] estimated
that 93% of the human genome is transcribed into RNA,
whereas only 2% of the human genome codes for
protein [7]. Therefore, most of the RNAs transcribed
from the human genome must be non-protein coding
transcripts, commonly called noncoding RNAs
(ncRNAs).
The limited number of long ncRNAs that have been
characterized to date exhibit diverse functions, as well
as cell type-specific expression and localization to sub-
cellular compartments. Further determination of the
functions of long ncRNAs will expand our understand-
ing of various fundamental biological processes. Many
recent efforts in transcript mapping and expression pro-
filing have provided a rough overview of putative
ncRNA functions. A major subset of ncRNAs associates
with specific chromosomal loci, where they may play a
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are involved in genomic imprinting accompanied by
structural changes to the chromosome [8-10]. HOTAIR
has been shown to recruit the PRC2 histone modifica-
tion complex, regulate specific HOX gene loci on differ-
ent chromosomes [11], and reprogram chromosomal
structure in a manner that leads to cancer metastasis
[12]. Furthermore, the PRC2 complex was found to
associate with hundreds of large intergenic non-coding
RNAs (lincRNAs) that were identified by a genome-wide
search based on the histone H3K36 code [13]. These
data indicate a general long ncRNA function in epige-
netic control of gene expression. Additionally, recent
reports have indicated that a subset of ncRNAs play
essential roles in intracellular substructure organization.
The MENε/b ncRNAs are essential for nuclear para-
speckle formation through their interaction with specific
RNA-binding proteins [14-16].
In contrast to their nuclear functions, little is known
about the cytoplasmic functions of long ncRNAs in
mammalian cells. The NRON ncRNA was reported to
associate with importin b in the cytoplasm and may reg-
ulate the nuclear transport of the NFAT transcription
factor upon calcium signaling [17]. The UHG and gas5
ncRNAs, which produce small nucleolar RNAs (snoR-
NAs) from their introns, are transported into the cyto-
plasm where they are rapidly degraded by nonsense-
mediated decay (NMD) [18-20]. Therefore, the spliced
exons of UHG and gas5 may be nonfunctional tran-
scripts. However, the gas5 ncRNA is involved in the
proliferation of a leukemia cell line, and a fragment of
the gas5 ncRNA acts as a riboregulator of a nuclear
receptor [21,22]. In plants, the ncRNA IPS1 acts as a
molecular decoy for a specific miRNA and attenuates
the effect of that miRNA on its target mRNA [23].
Cytoplasmic mRNA levels are controlled via various
mRNA degradation pathways that recognize the struc-
tural features of mRNAs targeted for degradation. Aber-
rant mRNAs with a premature termination codon (PTC)
are specifically recognized by RNA surveillance machin-
ery and committed to the NMD pathway [19]. The
NMD pathway also degrades UHG and gas5 ncRNAs
transported into the cytoplasm [18]. In mammalian
c e l l s ,h U P F 1t r i g g e r sN M Do fP T C - c o n t a i n i n gm R N A s
or ncRNAs and interacts with hUPF2, which associates
with the exon junction complex (EJC) on spliced mature
mRNAs [19]. Staufen1, which binds to a specific stem-
loop structure in the 3’UTR, also recruits hUPF1, and
the interaction elicits the degradation of the target
mRNAs [24]. hUPF1 was recently shown to interact
with RISC and be involved in the destabilization of
miRNA-targeted mRNAs [25].
Here, we identified long ncRNAs that are expressed
specifically in the thymus. The thymus is an organ
located in the upper anterior portion of the chest and is
the site of T-lymphocyte maturation. Therefore, thy-
mus-specific ncRNAs are intriguing candidates for fac-
tors involved in the regulation of thymus-specific
physiological events such as T-lymphocyte maturation.
One thymus-specific ncRNA, Thy-ncR1, was expressed
only in a few T-cell lines, all of which originated from
immature stage III T cells. Thy-ncR1 exhibits complex
alternative splicing to produce several isoforms. We
further identified a putative target mRNA that is con-
trolled by Thy-ncR1 via a novel hUPF1-dependent RNA
degradation pathway.
Results
The thymus-specific ncRNA, Thy-ncR1, is expressed in a
subset of leukemia T-cell lines
To identify long ncRNAs that are involved in thymus-
specific physiological events, we examined a microarray
dataset obtained using our original microarray to moni-
tor the expression of human non-protein coding tran-
scripts selected from the H-Invitational database http://
www.h-invitational.jp/hinv/ahg-db/index.jsp[26].
ncRNA-like transcripts that were predominantly
expressed in the thymus were selected based on a sim-
ple comparison of the microarray signals from human
thymus, brain, liver, and testis.
The thymus-specificity of each transcript was validated
by quantitative reverse transcription polymerase chain
reaction (qRT-PCR) using total RNA samples prepared
from 11 human organs, including the 4 listed above
(Additional file 1 Fig. S1). We selected 10 thymus-specific
ncRNAs that included three ncRNAs identified in our
primary screening of tissue-specific ncRNAs [27]. For
further characterization of the expression pattern of each
ncRNA during T-cell maturation in the thymus, 17
T-cell leukemia cell lines were examined. These leukemia
cell lines were originally derived from T cells at various
stages of maturation, and each cell line therefore partially
reflects the features of native T-cell maturation. The cell
lines were used for expression profiling of the 10
thymus-specific ncRNAs, and qRT-PCR analyses revealed
that the majority of the thymus-specific ncRNAs were
expressed in all 17 T-cell leukemia cell lines (Figure 1).
However, the expression of HIT14168 was restricted to
the T-cell lines DND41, HPB-ALL, Jurkat, and MOLT-3,
which are all derived from immature stage III T cells
[28,29] (Figure 1). This specific expression pattern sug-
gests that the HIT14168 ncRNA functions in some phy-
siological process specific to immature stage III T cells.
We further characterized this transcript, which we have
named thymus-specific ncRNA-1 (Thy-ncR1).
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CD1 gene cluster in a cell lineage-specific manner
The Thy-ncR1 gene is located at 1q23.1 on human
chromosome 1. This locus overlaps with a number of
olfactory receptor (OR) genes. Indeed, an OR10R2 gene
and a related OR pseudogene are encoded in the anti-
sense strand of the Thy-ncR1 gene. Since OR gene
expression is normally restricted to the olfactory bulb,
t h et h y m u s - s p e c i f i cT h y - n c R 1i su n l i k e l yt oc o n t r o lO R
genes. However, the possibility that this subset of OR
g e n e si se x p r e s s e dd u r i n gT - c e l lm a t u r a t i o na n dt h a t
Thy-ncR1 acts as a regulatory antisense RNA could not
be excluded. Therefore, the possible regulatory role of
Thy-ncR1 in OR10R2 gene expression was first
Figure 1 Expression profiles of thymus-specific ncRNAs in T-cell leukemia cell lines. Quantitation of each ncRNA by qRT-PCR is shown in
the graph. The expression level of the cell line showing the highest expression was defined as 100%. Bars represent the means ± SD of three
measurements. The following T-cell leukemia cell lines were used: 1, RPMI-8402; 2, H-SB2; 3, CCRF-CEM; 4, DND41; 5, HPB-ALL; 6, Jurkat; 7, MOLT-
3; 8, TALL-1; 9, MOLT-13; 10, MOLT-16; 11, PEER; 12, HUT-78; 13, MOTN-1; 14, MT-1; 15, SKW-3; 16, HUT-102; and 17, MT-2. The cell lines are
categorized into four types according to EGIL criteria (7). Type-T-II includes cell lines #1 and 2 (open graph bars); type-T-III includes lines #3 to #8
(black graph bars); type-T-IV includes lines #9 to #11 (light gray graph bars); and mature T includes lines #12 to #17 (dark gray graph bars).
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Page 3 of 12examined in the thymus and in the Jurkat T-cell leuke-
mia cell line. An RNase A/T1 protection assay using an
RNA probe covering the OR10R2 gene in exon 2 of
Thy-ncR1 revealed that OR10R2 gene expression was
undetectable both in thymus tissue and Jurkat cells,
whereas Thy-ncR1 was highly expressed (Additional file
1, Fig. S2A and S2B). This result strongly suggests that
Thy-ncR1 has a T-cell-specific function(s) independent
of OR gene expression.
The T-cell-related CD1 gene cluster is located at an
adjacent chromosomal locus, 118 kb from the Thy-ncR1
gene (Figure 2A). CD1 is a classical cell surface marker
antigen, which displays lipid antigens on the surface of
dendritic cells; however, its exact function in T cells
remains elusive [30]. Expression profiling of CD1 gene
family members (CD1a-1e) in the 17 T-cell leukemia
cell lines revealed that their expression correlated with
that of Thy-ncR1 (Figure 2B). Expression of CD1a, 1b,
1c, and 1e, which are class I CD1 proteins and more
proximal to Thy-ncR1, almost completely overlapped
with Thy-ncR1 expression with respect to both the cell
lines in which CD1a, 1b, 1c, and 1e were expressed and
their relative expression levels in those cell lines (Figure
2B). CD1 d, the only class II CD1 protein in the cluster,
was expressed with a similar pattern but more variably
than the class 1 CD1 genes (Figure 2B).
In rodents, class I CD1 genes have been lost from the
genome, resulting in only the class II CD1 d gene
remaining at the syntenic locus [31] (additional file 1,
F i g .S 3 ) .T h es e a r c hf o rap u t a t i v eT h y - n c R 1o r t h o l o g
near the CD1 d gene and at other loci in the mouse
genome by sequence comparison was unsuccessful,
Figure 2 Coordinated expression of Thy-ncR1 and CD1 gene cluster. A. Genomic location of Thy-ncR1 on chromosome 1 (q23.1). The CD1
gene cluster is adjacent to Thy-ncR1. The distance between each gene is shown below the diagram in kbp. B. The expression of the CD1 gene
family is highly correlated to Thy-ncR1 expression. Quantitation of each gene transcript by qRT-PCR is shown in the graph. The highest
expression level among the 17 cell lines was defined as 100% for each transcript. Bars represent means ± SD for three independent experiments.
C. Thy-ncR1 expression is cell-lineage specific. RT-PCR to detect Thy-ncR1, the CD1a and 1b gene transcripts, and the DC differentiation markers
CD14, CD80, and CD86.
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ome with the class I CD1 genes (Additional file 1, Fig.
S3). Thus, Thy-ncR1 may play a role in cooperation
with class I CD1 proteins in immature T cells or, alter-
natively, control class I CD1 gene expression in humans.
CD1 genes are expressed in dendritic cells (DC) as
well as in T cells. Therefore, the coordinated expression
of Thy-ncR1 and CD1 genes was then investigated in
the DC lineage. The expression of Thy-ncR1 as well as
CD1a and CD1b was monitored during differentiation
of DCs from CD14
+ monocytic cells [32]. In contrast to
T cells, Thy-ncR1 was not expressed during DC differ-
entiation, although the CD1 genes were expressed
(Figure 2C). This result clearly demonstrated that the
coordinated expression of Thy-ncR1 with the class 1
CD1 genes is T-cell lineage-specific.
Complex alternative splicing produces multiple Thy-ncR1
isoforms
According to the H-Invitational database, the Thy-ncR1
transcript (HIT14168) is estimated to be 2.6 kb in size
and composed of three exons. In our previous study,
northern hybridization to detect HIT14168 detected the
accumulation of a ~0.7-kb transcript in the thymus [27].
T h e s ed a t ai n d i c a t et h a tt h eT h y - n c R 1g e n ep r o d u c e s
several ncRNA isoforms, presumably by alternative spli-
cing. cDNA cloning based on EST data revealed the
existence of at least 4 different splicing isoforms, Ex1-2-
3 (= HIT14168), Ex1-3, Ex1-4-5, and Ex1-5, in the thy-
mus (Figure 3A). RNase protection assays using probes
covering the exon-exon junction of each splicing iso-
form revealed that Ex1-3 was the most abundant iso-
form in both thymus tissue (42%) and T-cell leukemia
Jurkat cells (70%). Ex1-3 is estimated to be 0.7 kb, cor-
responding to the transcriptp r e v i o u s l yd e t e c t e db y
northern hybridization analysis [27]. Northern hybridiza-
tion analysis with a probe corresponding to Ex1-3
detected a ~0.7-kb transcript in the thymus and in the
HPB-ALL and Jurkat T-cell leukemia cell lines, whereas
the Ex2 probe detected a 2.6-kb transcript that corre-
sponds to Ex1-2-3 with a similar expression specificity
(Figure 3C). The broad band corresponding to Ex1-3
(~0.7 kb) could be sharpened by RNase H treatment in
the presence of oligo dT, indicating that a heteroge-
neous population of the Ex1-3 transcript possessing poly
(A) tails exists (data not shown). Two Thy-ncR1 3’ ter-
mini were identified by 3’ RACE downstream of the
canonical poly (A) signals mapped at the ends of exon 3
and exon 5 (Figure 3A).
An RNase protection assay using the Ex1 probe (probe
I) detected several bands in addition to one correspond-
ing to the full-length exon 1 (Figure 3D and additional
file 1, Fig. S2C), suggesting that additional alternative
splicing sites are present within exon 1. Further cDNA
cloning and RNase protection assay of the exon 1 region
revealed that two additional splice sites existed in exon 1,
which resulted in the production of three exon 1 iso-
forms: exon 1b, exon 1c, and the unspliced exon (exon
1a) (Figure 3D). The additional exon 1-derived forms are
shown in Figure 3D (asterisks). Another RNase protec-
tion assay probe lacking 135 nt of the exon 1 5’ terminus
did not detect these bands (probe II in Additional file 1,
Fig. S2), suggesting that these transcripts correspond to
isoforms whose 5’ end is shifted downstream. Taken
together, the total number of Thy-ncR1 splicing isoforms
is estimated to be at least 24 (12 produced by variations
in exon combinations and an additional 12 produced by
the 5’ end heterogeneity).
Next, we investigated the levels of the three exon 1
isoforms linked to downstream exon 2, 3, or 4 by RT-
PCR using primer pairs for the exon 1 common primer
and various exon 2-4 specific primers (Figure 3E). Exon
1a was most frequently combined with exon 2 (Figure
3E, open circles), whereas exons 3 and 4 were more fre-
quently combined with exon 1b (Figure 3E, closed trian-
gles). The level of the exon 1c-3 isoform was
remarkably increased in SKW3 cells compared to the
other three T-cell lines (Figure 3E, open squares). In
contrast, exon 1c was rarely combined with exon 2 and
exon 4 in HPB-ALL cells (Figure 3E, bottom panel).
These results indicate that the exon combinations are
cell-type specific.
Thy-ncR1 transcripts are cytoplasmic but not susceptible
to NMD
The intracellular localization of each Thy-ncR1 isoform
was examined in HPB-ALL cells. The cells were homo-
g e n i z e da n ds e p a r a t e di n t on u c l e a ra n dc y t o p l a s m i c
fractions, followed by quantitation of Thy-ncR1 levels in
each fraction by qRT-PCR. As shown in Figure 4A, the
major splicing isoforms (Ex1-3, Ex1-2-3 and Ex1-4-5)
were localized to the cytoplasm, similar to typical
mRNAs (Figure 4A, GAPDH and b-actin). In contrast, a
large fraction of the precursor Thy-ncR1, which retains
intron 1 (Figure 4A, Int1-Ex2), was localized to the
nucleus, similar to b-actin precursor mRNA (Figure 4A,
actin intron). These results confirmed that the HPB-
ALL cells were successfully fractionated and that the
mature Thy-ncR1 transcript was localized to the cyto-
plasm. The same localization analysis was conducted in
Jurkat cells, and the nucleo-cytoplasmic distribution of
Thy-ncR1 isoforms was the same as that observed in
HPB-ALL cells (data not shown).
The data indicating that Thy-ncR1 is cytoplasmic raised
the possibility that Thy-ncR1 encodes a functional short
polypeptide. Sucrose density gradient analysis revealed
that Thy-ncR1 isoforms were commonly enriched in poly-
some-like fractions that were sensitive to EDTA treatment
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Page 5 of 12Figure 3 Complex alternative splicing to produce multiple Thy-ncR1 isoforms. A. Schematics of Thy-ncR1 isoform formation by alternative
splicing. The polyadenylation sites are shown. The olfactory receptor gene OR10R2 and a pseudogene (OR10K1) encoded in the antisense strand
are shown by the bold arrows. The exon numbers are shown below the diagram. B. The relative amounts of Thy-ncR1 isoforms. An RNase
protection assay using riboprobes spanning the exon-exon junction of each isoform was conducted using total RNA from thymus (T) and Jurkat
(J) cells. The negative control was yeast RNA (Y). The bands corresponding to each spliced isoform and the other isoforms in terms of each
riboprobe are shown by closed and open arrows, respectively. The ratio of each isoform in thymus and Jurkat cells, which was calculated by
dividing the band intensity of each isoform (closed arrow) by the sum of the band intensities of all isoforms (closed arrow + opened arrow), is
shown below. C. Northern hybridization analyses to detect Thy-ncR1 isoforms. The DNA probes used are shown above. D. Additional splicing
variants within exon 1. A schematic diagram of alternative splicing is shown above. RNase protection assay probe I derived from exon 1 is
indicated by an arrow. The patterns obtained by RNase protection assays are shown in the lower panel with a diagram for each isoform (Ex 1a,
1b, and 1c). E. The combination formed by each exon 1 isoform spliced to other exons. RT-PCR using the exon 1 primer that detects all exon 1
isoforms, and an exon 2, 3, or 4 primer was carried out with RNA prepared from thymus (T), HPB-ALL (H), Jurkat (J), and SKW3 (S) cells. Three
symbols (circle, triangle, and square) correspond to the exon 1 isoforms shown in D.
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Page 6 of 12(Additional file 1, Fig. S4). The Thy-ncR1 isoforms were
examined for ORFs, and the conservation of each ORF
was determined in four primate species where putative
Thy-ncR1 counterparts are predicted. In exon 1, which is
included in all the isoforms, the ORF located most proxi-
mal to the 5’ terminus consists of only 9 codons, and the
largest ORF consists of 34 codons (see Figure 4B and
Additional file 1, Fig. S5). The sequence alignment of the
first (9 codons) and the second (34 codons) ORFs between
the counterparts in four primates, humans, chimpanzees,
orangutans, and rhesus monkeys revealed that two of the
nine amino acids encoded in the first ORF were not con-
served in two primate species, and a termination codon
appeared at the fifth codon of the second ORF in rhesus
monkeys (Additional file 1, Fig. S5). These data strongly
suggest that these ORFs are unlikely to encode any func-
tional polypeptides.
Evidence indicating that some cytoplasmic ncRNAs are
degraded via the NMD pathway [18] raises the possibility
that Thy-ncR1 is an NMD target. The termination codon
of the ORF in the first exon would be recognized as a
premature termination codon (PTC) if translated. How-
ever, RNAi depletion of hUPF1 in Jurkat cells (Figure 4C)
to arrest NMD led to no obvious stabilization of any
Thy-ncR1 RNA isoforms. In contrast, the levels of gas5
and UHG, both known NMD targets, were significantly
elevated upon hUPF1 depletion (Figure 4D). This result
indicated that Thy-ncR1 is not susceptible to NMD.
Thy-ncR1 is a negative riboregulator of MFAP4 gene
expression
To examine the biological function of Thy-ncR1, each iso-
form was selectively degraded using RNAi in HPB-ALL
cells. The siRNA 1, which corresponds to a sequence in
exon 1, depleted all isoforms, while siRNA 3-1 and 3-2
depleted two major isoforms (Ex1-2-3 and Ex1-3), and
siRNA 4 specifically depleted the Ex1-4-5 isoform (Figure
5A and 5B). Microarray analysis and subsequent qRT-PCR Figure 4 Thy-ncR1 transcripts are cytoplasmic but are not
susceptible to NMD. A. Subcellular distribution of Thy-ncR1
isoforms. HPB-ALL cells were fractionated into nuclear and
cytoplasmic fractions. RNA prepared from each fraction was used for
qRT-PCR analyses. The levels of Thy-ncR1 isoforms (exon 1-3, 2-3,
and 4-5) and precursor retaining intron 1 (int1-ex2) were quantified
in the nuclear and cytoplasmic fractions. GAPDH and b-actin mRNA
are the controls for cytoplasmic RNA, and b-actin pre-mRNA (actin
intron) is the control for nuclear RNA. Thy-ncR1 is not susceptible to
NMD. B. Potential ORFs (closed boxes) in Thy-ncR1 exons. The scales
(nt) are shown below the diagram. C. Depletion of hUPF1 from
Jurkat cells treated with siRNA (si-hUPF1) was confirmed by
immunoblot analysis with anti-hUPF1 antibody. D. qRT-PCR analyses
of Thy-ncR1 isoforms and known NMD targets (gas5 and UHG) in
control (NC, adjusted to 100%) and hUPF1-depleted cells (si-hUPF1)
as shown in B. Bars represent means ± SD for three independent
experiments.
Figure 5 Thy-ncR1 controls MFAP4 mRNA levels.A .I s o f o r m -
specific knockdown of Thy-ncR1. The positions of siRNAs designed
to knockdown specific Thy-ncR1 isoforms are shown. Isoforms that
could be degraded by each siRNA are shown below the arrow.
B. Confirmation of Thy-ncR1 knockdown. The levels of Thy-ncR1
isoforms were determined by qRT-PCR. C. Increase in MFAP4 mRNA
upon Thy-ncR1 knockdown. The MFAP4 mRNA level in Thy-ncR1
knockdown cells was determined by qRT-PCR. D. RNA hybridization
to detect MFAP4 mRNA in HPB-ALL cells treated with control and
siRNA 1 of Thy-ncR1.
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was controlled by Thy-ncR1 isoforms. Microfibril-
associated glycoprotein 4 (MFAP4) mRNA was elevated
~2.5-fold upon depletion of Thy-ncR1 isoforms with
siRNAs 1, 3-1, and 3-2, but not siRNA 4 (Figure 5C).
Northern hybridization revealed that MFAP4 mRNA
accumulated as a single isoform of ~2 kb, and its level
increased without any changes in mRNA length upon
Thy-ncR1 knockdown (Figure 5D).
Possible involvement of Thy-ncR1 in a novel hUPF1-
dependent pathway for MFAP4 mRNA degradation
The MFAP4 mRNA level increased ~2-fold in response
to hUPF1 knockdown, which was an increase similar to
that of the known NMD targets, gas5 and UHG, in Jurkat
cells (Figure 6A). MFAP4 mRNA appears to be a normal
mRNA since no PTCs are predicted according to the
sequence information of the cDNA clones in the public
databases. This observation suggests that MFAP4 mRNA
was unlikely to be subjected to NMD. Intriguingly,
hUPF2 RNAi did not change the MFAP4 mRNA level,
whereas gas5 and UHG levels were significantly elevated
(Figure 6B). These results were confirmed with different
siRNAs against hUPF1 or hUPF2 (data not shown).
These data indicate that MFAP4 mRNA is degraded by a
hUpf1-dependent pathway distinct from NMD.
The RNA-binding protein Staufen 1 binds to a specific
stem-loop structure in the 3’UTRs of hUPF1-target
mRNAs and recruits hUpf1 to those mRNAs [24]. Our
search for such a stem-loop structure failed to identify any
typical structure in the 3’UTR of MFAP4 mRNA. Further-
more, Staufen 1 RNAi led to no obvious alteration in the
MFAP4 mRNA level in Jurkat cells (data not shown),
suggesting that hUpf1 was recruited to MFAP4 mRNA via
an unidentified factor. Coimmunoprecipitation using a
hUpf1 antibody revealed that MFAP4 mRNA, as well as
other known NMD and SMD targets, was efficiently preci-
pitated with the hUpf1 antibody, confirming the associa-
tion of hUPF1 with MFAP4 mRNA (Figure 6C).
Next, the relationship between hUPF1-dependent
MFAP4 mRNA degradation and Thy-ncR1 was examined.
As shown in Figure 6D, Thy-ncR1 was depleted in the pre-
sence and absence of hUPF1 to examine whether these
two factors are involved in different pathways for destabi-
lizing MFAP4 mRNA. The level of MFAP4 mRNA
increased 2-fold upon Thy-ncR1 depletion (Figure 6E,
control siRNA). However, no obvious further elevation in
the MFAP4 mRNA level was observed in the absence of
hUPF1 (Figure 6E, si-hUPF1), suggesting that Thy-ncR1
acts to suppress MFAP4 gene expression via the same
pathway as that of hUPF1-dependent degradation.
Discussion
Thy-ncR1 is transcribed from chromosome 1q23.1 within
the OR gene cluster. However, Thy-ncR1 was expressed
o n l yi nt h et h y m u s ,w h e r et h eO Rg e n e sw e r en o t
expressed. The expression of the CD1 gene cluster,
located 118 kb from Thy-ncR1, was highly correlated
with Thy-ncR1 expression in the T-cell lineage, but not
in the DC-cell lineage. Thus, the Thy-ncR1 gene was spe-
cifically expressed at one stage of T-cell maturation.
Expression of Thy-ncR1 may be mechanistically linked to
the activation of the CD1 gene cluster expression but not
to the expression of the surrounding OR gene cluster.
Our attempts to disrupt Thy-ncR1 function by RNAi
were limited, since RNAi may inefficiently degrade the
nuclear-localized fraction of Thy-ncR1. The nuclear
function of Thy-ncR1 must be examined in future stu-
dies to determine whether a mechanistic link exists
between the expression of Thy-ncR1 and the CD1 gene
cluster. In yeast and fly, ncRNA transcription affects the
expression of adjacent genes through transcriptional
interference [33,34]. Recently, ncRNA transcription was
reported to lead to stepwise chromatin remodeling in
the promoter region and activation of the fbp1(+) gene
in Schizosaccharomyces pombe [35]. These data suggest
that Thy-ncR1 may affect CD1 gene expression in cis by
Figure 6 MFAP4 mRNA level is regulated by a unique hUPF1-
dependent pathway. A, B. Effects of the knockdown of human
NMD factors on MFAP4 mRNA. RNAi was conducted using control
siRNA, hUPF1-targeted siRNA (si-hUPF1, in A), or hUPF2-targeted
siRNA (si-hUPF2-1, in B) in Jurkat cells. C. Co-immunoprecipitation of
MFAP4 mRNA from HPB-ALL cell extracts with anti-hUPF1 antibody.
Known NMD targets (gas5 and UHG) and SMD targets (Arf1 and c-
jun) were used as positive controls. D, E. Double knockdown of Thy-
ncR1 and hUPF1. Immunoblot confirmed the depletion of hUPF1
upon treatment with si-hUPF1 in the presence or absence of si-
RNA1 against Thy-ncR1 (D). qRT-PCR of MFAP4, gas5, and Thy-ncR1
in Jurkat cells that were treated with each combination of siRNAs
shown.
Aoki et al. BMC Molecular Biology 2010, 11:99
http://www.biomedcentral.com/1471-2199/11/99
Page 8 of 12a chromosome-associated mechanism that would be dif-
ficult to interrupt with Thy-ncR1 RNAi. Since no mouse
counterpart has been identified, chromosomal manipula-
tion of the Thy-ncR1 gene in human T-cell lines will be
required to explore the nuclear functions of this
transcript.
The Thy-ncR1 transcript is likely to be transcribed by
RNA polymerase II, as its biogenesis pathway is similar
to that of an mRNA, including export to the cytoplasm.
Alternative splicing events and putative alternative tran-
scription start sites are able to create at least 24 different
Thy-ncR1 isoforms. The intracellular distribution of the
Thy-ncR1 isoforms was mostly cytoplasmic, where they
were enriched in the small polysome-like fractions. The
distribution of the putative target mRNA MFAP4 did not
overlap with any of the Thy-ncR1 isoforms in the sucrose
gradient fractionation (data not shown), suggesting that
the effect of Thy-ncR1 on MFAP4 mRNA stability is
indirect and, presumably, mediated by specific regulatory
factor(s). Northern hybridization analysis demonstrated
that MFAP4 transcript size was unchanged by Thy-ncR1
depletion. The unspliced MFAP4 pre-mRNA level
remained constant after Thy-ncR1 depletion (data not
shown). These data strongly suggest that Thy-ncR1
depletion results in the destabilization of the mature
MFAP4 mRNA rather than affecting transcription or
splicing regulation. A sequence comparison of Thy-ncR1
with MFAP4 mRNA revealed that a short pyrimidine
stretch (~30 nt) located downstream of the MFAP4
mRNA initiation codon is similar to a sequence in exon 3
of Thy-ncR1 (Additional file 1, Fig. S6). This similarity
suggests the intriguing possibility that Thy-ncR1 acts to
capture an MFAP4 mRNA stabilizing factor recognizing
the pyrimidine-rich stretch. This model would explain
how Ex1-3 and Ex1-2-3, but not Ex1-4-5, can influence
MFAP4 mRNA levels. The various splicing isoforms may
play distinct regulatory roles in the cytoplasm, one of
which is to regulate MFAP4 mRNA stability.
MFAP4 mRNA was destabilized via a hUPF1-dependent
pathway in Jurkat cells. RNAi depletion of hUPF1 stabi-
lized MFAP4 mRNA, and a hUPF1 antibody co-immuno-
precipitated MFAP4 mRNA. Translation arrest with
cycloheximide also stabilized MFAP4 mRNA, indicating
that hUPF1 is involved in a translation-dependent mRNA
degradation pathway (data not shown). The evidence that
MFAP4 mRNA possesses no putative PTCs and that
neither hUPF2 nor Staufen 1 is involved in MFAP4
mRNA destabilization indicates that a novel hUPF1-
dependent mRNA decay pathway regulates the MFAP4
mRNA level in Jurkat cells. Identification of a new hUPF1
adaptor may be the next step in defining the molecular
mechanism of this mRNA degradation pathway.
Our results here demonstrated that Thy-ncR1 acts to
reduce the level of MFAP4 mRNA. A double-knockdown
experiment suggested that the Thy-ncR1-dependent
pathway overlaps with the hUPF1-dependent pathway for
MFAP4 mRNA degradation. We confirmed that hUPF1
association with MFAP4 mRNA is not altered in the pre-
sence or absence of Thy-ncR1 and that Thy-ncR1 iso-
forms were poorly co-immunoprecipitated with anti-
hUPF1 antibody, suggesting that Thy-ncR1 is not directly
involved in hUPF1 binding to MFAP4 mRNA (data not
shown). Thy-ncR1 may indirectly control a cytoplasmic
regulatory factor that modulates the activity of hUPF1 or
other factors involved in this decay pathway.
MFAP4 encodes a polypeptide that contains a fibro-
nectin-like domain for cell adhesion. A recent report
revealed that MFAP4 facilitates the ex vivo expansion of
hematopoietic stem cells, suggesting that MFAP4 acts as
an angiopoietin-like growth factor [36]. The specific
physiological role of MFAP4 in immature T cells
remains to be clarified. Elucidation of the physiological
role of MFAP4 may also reveal the significance of the
regulation of MFAP4 gene expression by the thymus-
specific riboregulator, Thy-ncR1.
Conclusions
In summary, our results show that Thy-ncR1 ncRNA is
a functional cytoplasmic “riboregulator” at one specific
stage of T-cell maturation. Thy-ncR1 controls the abun-
dance of MFAP4 mRNA, which is degraded via an
uncharacterized hUPF1-dependent degradation pathway.
Methods
Cell lines
HPB-ALL and Jurkat cells were cultured in RPMI medium
supplemented with 10% fetal bovine serum (FBS) and
grown in a humidified incubator (5% CO2) at 37°C. Jurkat
cells were plated at a density of 2-3 × 10
5 cells/ml and
used in experiments after a 24 h incubation. HPB-ALL
cells were plated at a density of 1 × 10
6 cells/ml and used
in experiments after a 48 h incubation. Induction of CD14
+ cell differentiation into dendritic cells (DC) was per-
formed as described previously with some modifications
[32]. Briefly, CD14
+ umbilical cord blood monocytes were
enriched using a magnetic cell sorter and then cultured in
alpha-MEM containing 10 ng/ml of each of recombinant
human GM-CSF and IL-4 for 7 days. Lipopolysaccharide
(1 μg/ml) was added to the culture during the last 24 h to
complete the maturation of the DC.
RNA analyses
Total RNA was prepared using Trizol (Invitrogen) or
Sepasol (Nacalai). RNase protection assays were per-
formed as described previously [37]. PCR fragments that
cover each ncRNA region were cloned into the pGEM-T
Easy vector (Promega), followed by digestion with an
appropriate restriction enzyme for in vitro transcription.
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32P-labeled
antisense RNA probe that was synthesized using the T7
or SP6 RNA polymerase (TaKaRa). RNase A/T1 digestion
removed single-stranded RNA. The protected RNA frag-
ments were separated by polyacrylamide gel electrophor-
esis (PAGE) on an 8% gel containing 7 M urea.
Radioactive RNA bands were visualized using Fuji
BAS3000 Bioimaging Analyzer. For northern hybridiza-
tion, total RNA was run on an 8% PAGE gel containing 7
M urea followed by electroblotting onto a Hybond N
+
nitrocellulose membrane (GE Healthcare Life Sciences).
The blotted RNAs were covalently fixed to the mem-
brane by UV crosslinking. Radiolabeled DNA probes
were synthesized from cDNA fragments using a DNA
labeling Kit (Takara) and hybridized in ExpressHyb™
Hybridization Solution (Clontech) at 50°C overnight. The
membrane was washed, and radiolabeled RNA bands
were visualized using Fuji BAS3000 Bioimaging Analyzer.
Quantitative reverse transcription polymerase chain
reaction (qRT-PCR) was performed as described [18].
Briefly, total RNA (1 μg) was reverse transcribed using the
QuantiTect reverse transcription kit (Qiagen). Primers
were designed using Primer3 software http://www-gen-
ome.wi.mit.edu/ftp/distribution/software/ and purchased
from Invitrogen. Aliquots of cDNA were subjected to real-
time PCR performed using LightCycler 480 SYBR Green I
Master (Roche Diagnostics) according to the manufac-
turer’s protocol. No amplification was observed when
reverse transcriptase was omitted. Primer sequences for
qRT-PCR are provided in Additional file 1, Table S1.
RNAi
Stealth siRNAs for Thy-ncR1, hUPF1, and hUPF2 were
synthesized by Invitrogen, and an siRNA for hUPF1 was
synthesized by Proligo. A Stealth™ RNAi Negative Control
Kit (Invitrogen) and Silencer® Negative Control #1 siRNA
(Ambion, Inc.) were used for negative controls. Prior to
transfection, cells were cultured in medium containing
10% FBS without antibiotics. Subsequently, 2 × 10
6 Jurkat
or HPB-ALL cells were resuspended in 100 μL Nucleofec-
tor Solution-V (Amaxa) and mixed with 400 pmol stealth
siRNA for Thy-ncR1 or 200 pmol siRNA for hUPF1 and
hUPF2. The siRNA transfection used the G-010 protocol
according to the manufacturer’s instructions (Amaxa).
The cells were plated in RPMI1640 medium containing
10% FBS. After 48 h, total RNA was prepared using an
RNeasy kit (Qiagen). Sequences of the siRNAs are pro-
vided in Additional file 1, Table S2.
DNA Microarray
HPB-ALL cells were nucleofected with control siRNA,
siRNA1, siRNA3-1, or siRNA3-2, and incubated for
48 h. Total RNA was then prepared and labeled with
Cy3. Samples were hybridized to a Human Oligo Micro-
array (G4112F, Agilent) according to the manufacturer’s
protocol. Arrays were scanned with a G2565BA Micro-
array Scanner System (Agilent), and the resulting data
were analyzed using the GeneSpring GX software (Agi-
lent). The microarray analysis to monitor human non-
protein coding transcripts was conducted as described
previously [26]. The raw data are available in Center for
Information Biology Gene Expression Database (CIBEX;
http://cibex.nig.ac.jp)(accession number: CBX142).
Additional material
Additional file 1: Supplemental Figures. Supplemental Figure S1. The
expression profiles of 10 ncRNAs that are predominantly expressed in
thymus. qRT-PCR was conducted to measure the levels of each ncRNA in
11 human tissues (1, brain; 2, thymus; 3, heart; 4, lung; 5, liver; 6, spleen;
7, kidney; 8, testis; 9, placenta; 10, prostate; and 11, skeletal muscle). The
levels in thymus were defined a 100%. Supplemental Figure S2. A. RNase
protection assays to detect transcripts derived from exon 1 and exon 2.
B. Confirmation of the absence of the OR10R2 transcript in the thymus.
An RNase protection assay was conducted to detect OR10R2 mRNA
using a sense probe (S) and Thy-ncR1 using an antisense probe (AT). The
Thy-ncR1 transcripts detected by the AT probe are shown by the arrows.
Detection of additional isoforms may indicate differential usage of 5’ end
start sites. Supplemental Figure S3. Genomic structure of the CD1 gene
cluster, the Thy-ncR1 locus, and neighboring genes in human (above)
and their counterparts in mouse. Supplemental Figure S4. Polysome
profiles of Thy-ncR1 isoforms. The cell extract prepared from HPB-ALL
cells treated with cycloheximide was subjected to 15-45% sucrose
density gradient centrifugation (left panels). Sucrose density gradient
centrifugation was carried out with an HPB-ALL cell extract treated with
50 mM EDTA (right panels). RNA prepared from each fraction was used
for qRT-PCR. The amount of transcript in each fraction relative to the
total RNA was calculated and shown in the bottom panel. Supplemental
Figure S5. A. Amino acid sequences encoded by potential ORFs in Thy-
ncR1 isoforms and their conservation among four primate species. B.
Potential ORFs in the gas5 and UHG ncRNAs. Supplemental Figure S6.
Significant sequence similarity between a region in the MFAP4 mRNA
and the Thy-ncR1 exon 3 (red letters). Supplemental table S1-Primer
Sequences using for RT-PCR. Supplemental table S2-siRNA Sequences
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